Dr. Massimo Bottini is an Associate Professor at the University of Rome Tor Vergata (Rome, Italy) and an Affiliate Associate Professor at the Sanford Burnham Prebys (La Jolla, USA). In previous positions, he has been an Adjunct Investigator at the Moores Cancer Center of the University of California San Diego (La Jolla, USA) and a Visiting Professor at the National Center for Nanoscience and Technology of the University of the Chinese Academy of Sciences (Beijing, People’s Republic of China). He teaches Biochemistry at the Faculty of Medicine and Surgery of the University of Rome Tor Vergata and Nanomedicine at the Faculty of Medical Engineering of the same campus. He leads the “Laboratory of Biochemistry Nanotechnology” at the Department of Experimental Medicine of the University of Rome Tor Vergata. His research is mostly focused on the study of the biochemical and biophysical properties of extracellular vesicles and the development of nanomedicines to treat cancer and arthritic diseases. He has been the recipient of multiple fellowships/grants from the Juvenile Diabetes Research Foundation, Arthritis National Research Foundation, European Commission, and Italian Ministry for Education, University and Research.